Tricyclic antidepressant plasma levels and adverse effects after overdose
Authors:
- 1 January 1977
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 21 (1) , 47-51
Abstract
Forty patients ingesting tricyclic antidepressant (TAD) overdoses were studied as a pharmacologic model to determine whether total tricyclic antidepressant plasma levels correlated with major adverse effects and electrocardiographic findings. Maximum TAD plasma levels were higher in patients who died (p < 0.025) or had cardiac arrest (p < 0.02), needed respiratory support (p < 0.005), were unconscious (p < 0.02), had grand mal seizures (p < 0.001), ventricular rate ≥ 120/min (p < 0.01), cardiac arrhythmia (p < 0.05), QRS duration ≥ 100 msec (p < 0.00l), or bundle branch block (p < 0.05). TAD plasma levels correlated with the dose ingested by history (N = 29, r = 0.58, p < 0.001). Measurement of total TAD (free and protein‐bound) appears to correlate well with biologic response.Keywords
This publication has 5 references indexed in Scilit:
- Nortriptyline plasma levels and therapeutic responseClinical Pharmacology & Therapeutics, 1976
- Commentary; Present status of clinical psychopharmacologyClinical Pharmacology & Therapeutics, 1976
- Amitriptyline plasma levels and therapeutic responseClinical Pharmacology & Therapeutics, 1976
- Plasma levels and antidepressive effect of imipramineClinical Pharmacology & Therapeutics, 1976
- Electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasmaJournal of Pharmaceutical Sciences, 1976